Who owns CHROMOCELL THERAPEUTICS CORP COM?
- Ticker: CHRO
- CUSIP Number: 171126105
Tip: Access positions for across all investors
Analyze quarterly positions in Chromocell Therapeutics Corp with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Chromocell Therapeutics Corp stock
Who bought or sold CHROMOCELL THERAPEUTICS CORP COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Honkamp Krueger Financial Services | 47k | $34k | 100% | Sep 2024 |
|
| Two Sigma Securities | 26k | $19k | 100% | Sep 2024 |
|
| Wealth Enhancement Advisory Services | 10k | $7.4k | 100% | Dec 2024 |
|
| Tower Research Capital | 259.00 | $183.993600 | 4217% | Sep 2024 |
|
| Bank of America Corporation | 11.00 | $8.000300 | 22% | Sep 2024 |
|
Who sold out of Chromocell Therapeutics Corp?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Frigate Ventures | Jun 2024 | 201k | $265k |
| Citadel Advisors | Jun 2024 | 19k | $25k |
| UBS Group | Jun 2024 | 186.00 | $246.003600 |